Skip to main content
logo
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
243.91
-7.16 (-2.85%)
At close: Jul 31, 2026, 4:00 PM EDT
243.80
-0.11 (-0.05%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
YORVIPATH Revenue
629.62M477.41M28.73M
SKYTROFA Revenue
198.78M206.16M197.00M
Commercial Products Revenue
828.40M683.57M225.73M
Services and Clinical Supply Revenue
19.59M18.01M15.57M
Licenses Revenue
4.87M5.63M122.34M
Milestones Revenue
-12.92M-
Revenue (Other)
12.92M--
Revenue (Total)
865.78M720.13M363.64M

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
681.78M546.39M233.12M
Europe Revenue
135.94M120.95M123.34M
Rest of World Revenue
48.06M52.80M7.19M
Revenue (Total)
865.78M720.13M363.64M

Key Performance Indicators

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Number of Unique U.S. Patient Enrollments - YORVIPATH
6.30K5.30K908.00
Number of Unique Prescribing Healthcare Providers - YORVIPATH
2.70K2.40K539.00